Study: NCT02517957

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Furoic acid loperamide hydrochloride cream
Description: Apply to lesion area without erosion, drainage, 1 times a day, continuous use 1 week after according to disease reduction or withdrawal, the longest do not exceed 4 weeks. Pure dry area or no skin itching area should not be applied.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Furoic acid loperamide hydrochloride cream
Description: Apply to lesion area without erosion, drainage, 1 times a day, continuous use 1 week after according to disease reduction or withdrawal, the longest do not exceed 4 weeks. Pure dry area or no skin itching area should not be applied.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Furoic acid loperamide hydrochloride cream
Description: Apply to lesion area without erosion, drainage, 1 times a day, continuous use 1 week after according to disease reduction or withdrawal, the longest do not exceed 4 weeks. Pure dry area or no skin itching area should not be applied.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mullite ointment
Description: Applies to a blister, pustule, erosion, ulcer, leaking or comorbid folliculitis, in skin lesions of 2 times a day, 5 days for one period of treatment, but for two consecutive period of treatment

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Mullite ointment
Description: Applies to a blister, pustule, erosion, ulcer, leaking or comorbid folliculitis, in skin lesions of 2 times a day, 5 days for one period of treatment, but for two consecutive period of treatment

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Mullite ointment
Description: Applies to a blister, pustule, erosion, ulcer, leaking or comorbid folliculitis, in skin lesions of 2 times a day, 5 days for one period of treatment, but for two consecutive period of treatment

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 3% boric acid solution
Description: 3% boric acid solution is suitable for the erosion seepage skin, can open intermittent shi fu, 5-10 min each time, 2 times daily or several times.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 3% boric acid solution
Description: 3% boric acid solution is suitable for the erosion seepage skin, can open intermittent shi fu, 5-10 min each time, 2 times daily or several times.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 3% boric acid solution
Description: 3% boric acid solution is suitable for the erosion seepage skin, can open intermittent shi fu, 5-10 min each time, 2 times daily or several times.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Zine oxide
Description: In wet apply the break to zinc oxide preparation for external use only, when erosion seepage control is disabled in skin lesions.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Zine oxide
Description: In wet apply the break to zinc oxide preparation for external use only, when erosion seepage control is disabled in skin lesions.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Zine oxide
Description: In wet apply the break to zinc oxide preparation for external use only, when erosion seepage control is disabled in skin lesions.